Adjuvant Therapy for Breast Cancer Using DOXOrubicin and Cyclophosphamide
Neoadjuvant or Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide followed by PACLitaxel
Neoadjuvant or Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel and Trastuzumab
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab
Neoadjuvant or Adjuvant therapy for Early Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by Weekly PACLitaxel
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Anastrozole in Postmenopausal Women
Therapy of Adjuvant Breast Cancer using Capecitabine
Adjuvant Therapy for High-Risk Breast Cancer Using Cyclophosphamide (oral), Methotrexate and Fluorouracil
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Cyclophosphamide, DOXOrubicin and DOCEtaxel
Adjuvant Therapy for Breast Cancer Using DOCEtaxel and Cyclophosphamide
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using DOCEtaxel, CARBOplatin, and Trastuzumab
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Exemestane in Postmenopausal Women
Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin, Cyclophosphamide and DOCEtaxel
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab
Adjuvant Therapy for Breast Cancer using Trastuzumab Emtansine (KADCYLA)
Neoadjuvant or Adjuvant Therapy for Breast Cancer using Letrozole in Postmenopausal Women
Neoadjuvant or Adjuvant Ovarian Suppression and Aromatase Inhibitor in Premenopausal Women with High Risk Early Stage Breast Cancer
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using a LHRH Agonist and Tamoxifen
Adjuvant Therapy for Breast Cancer in Post-menopausal Women Using Pamidronate
Alternative Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE)
Alternative Neoadjuvant or Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE), CARBOplatin and Trastuzumab
Alternative Adjuvant Therapy for Breast Cancer using PACLitaxel NAB (ABRAXANE) and Trastuzumab
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Tamoxifen
Neoadjuvant or Adjuvant Therapy for Breast Cancer Using Trastuzumab, DOCEtaxel and Cyclophosphamide
Adjuvant Therapy for Breast Cancer Using Trastuzumab following the Completion of Chemotherapy (Sequential)
Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab
Adjuvant Therapy for Breast Cancer in Post-Menopausal Women Using 3-Monthly Zoledronic Acid
Adjuvant Therapy for Breast Cancer in post-menopausal Women Using 6-Monthly Zoledronic Acid
Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel
Treatment of Locally Advanced Breast Cancer Using DOXOrubicin and Cyclophosphamide Followed by DOCEtaxel and Trastuzumab
Alternative NEOAdjuvant Therapy for Triple Negative Breast Cancer using CARBOplatin and PACLitaxel NAB (ABRAXANE) Followed by DOXOrubicin and Cyclophosphamide
Alternative NEOAdjuvant Therapy for Triple Negative Breast Cancer using Dose Dense Therapy: CARBOplatin and PACLitaxel NAB (ABRAXANE) Followed by DOXOrubicin and Cyclophosphamide
NEOAdjuvant Therapy for Triple Negative Breast Cancer Using Carboplatin and Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
NEOAdjuvant Therapy for Triple Negative Breast Cancer using Dose Dense Therapy: Carboplatin and Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
Alternative NEOAdjuvant Therapy for Locally Advanced Breast Cancer using PACLitaxel NAB (ABRAXANE) followed by DOXOrubicin and Cyclophosphamide
Alternative NEOAdjuvant Therapy for Breast Cancer using Dose Dense Therapy: PACLitaxel NAB (ABRAXANE) followed by DOXOrubicin and Cyclophosphamide
NEOAdjuvant Therapy for Breast Cancer Using Dose Dense Therapy: PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
NEOAdjuvant Therapy for Locally Advanced Breast Cancer Using Weekly PACLitaxel Followed by DOXOrubicin and Cyclophosphamide
Palliative Therapy for Metastatic Breast Cancer Using Weekly DOXOrubicin
Palliative Therapy for Metastatic Breast Cancer Using DOXOrubicin and Cyclophosphamide
Palliative Therapy for Metastatic Breast Cancer using PACLitaxel NAB (ABRAXANE)
Palliative Therapy for Metastatic Breast Cancer Using Anastrozole
Therapy for Metastatic Breast Cancer Using Capecitabine
For Therapy of Bone Metastases in Breast Cancer Using Oral Clodronate
Palliative Therapy for Advanced Breast Cancer Using Cyclophosphamide, Methotrexate and Fluorouracil
Palliative Therapy for Metastatic Breast Cancer Using Metronomic Low-Dose Oral Cyclophosphamide and Methotrexate
Palliative Therapy for Metastatic Breast Cancer Using DOCEtaxel
PalliativeTherapy for Metastatic Breast Cancer Using Weekly Docetaxel
Palliative Therapy for Metastatic Breast Cancer Using eriBULin
Therapy for Advanced Breast Cancer Using Everolimus and Exemestane
Palliative Therapy for Advanced Breast Cancer Using Exemestane
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine and DOCEtaxel
PalliativeTherapy for Metastatic Breast Cancer Using CISplatin and Gemcitabine
Palliative Therapy for Metastatic Breast Cancer Using Gemcitabine and PACLitaxel
Treatment of Meningeal Disease using High-Dose Methotrexate with Leucovorin Rescue
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab Emtansine (KADCYLA)
Therapy for Metastatic Breast Cancer Using Capecitabine and Lapatinib
Palliative Therapy for Advanced Breast Cancer Using Letrozole
Therapy for Advanced Breast Cancer Using a LHRH Agonist and an Aromatase Inhibitor
Palliative Therapy for Breast Cancer Using a LHRH agonist and tamoxifen
Palliative Therapy for Advanced Breast Cancer Using Megestrol
Palliative Therapy for Symptomatic Metastatic Breast Cancer Using Vinorelbine
Therapy of Advanced Breast Cancer Using Palbociclib and Aromatase Inhibitor With or Without LHRH Agonist
Prevention of Skeletal Related Events Secondary to Breast Cancer Metastases Using Pamidronate
Therapy of Advanced Breast Cancer using Palbociclib and Fulvestrant With or Without LHRH Agonist
Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab, and DOCEtaxel as First-Line Treatment for Advanced Breast Cancer
Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab, and PACLitaxel as First-Line Treatment for Advanced Breast Cancer
Palliative Therapy for Metastatic Breast Cancer using PERTuzumab, Trastuzumab, and Vinorelbine as First-Line Treatment for Advanced Breast Cancer
Therapy of Advanced Breast Cancer using Ribociclib and Fulvestrant With or Without LHRH Agonist
Therapy of Advanced Breast Cancer Using Ribociclib and Aromatase Inhibitor With or Without LHRH Agonist
Palliative Therapy for Breast Cancer Using Tamoxifen
Palliative Therapy for Metastatic Breast Cancer Using PACLitaxel
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab and Capecitabine
Palliative Therapy for Metastatic Breast Cancer Using Testosterone Enanthate
Palliative Therapy for Metastatic Breast Cancer Using Trastuzumab
PalliativeTherapy for Metastatic Breast Cancer Using Trastuzumab and Vinorelbine
Palliative Therapy for Metastatic Breast Cancer using Trastuzumab, Tucatinib, and Capecitabine
Palliative Therapy for Metastatic Breast Cancer Using Weekly PACLitaxel (3 Weeks Out of 4 Weeks Schedule)
Treatment of Acute Bone Pain Secondary to Breast Cancer Metastases Using IV Zoledronic Acid
